Eisai
4523.T
#2387
Rank
C$11.20 B
Marketcap
C$39.70
Share price
2.50%
Change (1 day)
11.77%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): C$1.17

According to Eisai's latest financial reports the company's current EPS (TTM) is C$1.22. In 2026 the company made an earnings per share (EPS) of C$1.22 a decrease over its 2025 EPS that were of C$1.54.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026C$1.22-21.04%
2025C$1.5411.85%
2024C$1.38-32.63%
2023C$2.045.52%
2022C$1.94-74.01%
2021C$7.45-66.58%
2020C$22.3098.24%
2019C$11.2517.01%
2018C$9.6137.78%
2017C$6.98-27.62%
2016C$9.6435.33%
2015C$7.12-2.82%
2014C$7.33-27.66%
2013C$10.13-27.49%
2012C$13.98-12.67%
2011C$16.0088.08%
2010C$8.51-11.06%
2009C$9.57-390.15%
2008C-$3.30-127.78%
2007C$11.87347.11%
2006C$2.664.38%
2005C$2.547.4%
2004C$2.3743.03%
2003C$1.6625.09%
2002C$1.3252.67%
2001C$0.8769.76%
2000C$0.51